Total Payments
$5,709
2024 Payments
$176.96
Companies
49
Transactions
272
Medicare Patients
832
Medicare Billing
$27,142
Payment Breakdown by Category
Food & Beverage$5,141 (90.0%)
Education$568.08 (10.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,141 | 265 | 90.0% |
| Education | $568.08 | 7 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $612.44 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $597.86 | 38 | $0 (2023) |
| Daiichi Sankyo Inc. | $539.83 | 21 | $0 (2022) |
| Lilly USA, LLC | $455.85 | 21 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $376.94 | 17 | $0 (2023) |
| Seagen Inc. | $227.30 | 16 | $0 (2022) |
| Incyte Corporation | $222.04 | 7 | $0 (2023) |
| Eisai Inc. | $178.55 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $163.45 | 9 | $0 (2023) |
| EMD Serono, Inc. | $161.80 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176.96 | 3 | Highridge Medical LLC ($137.95) |
| 2023 | $1,474 | 64 | Janssen Biotech, Inc. ($225.34) |
| 2022 | $1,930 | 100 | Novartis Pharmaceuticals Corporation ($300.10) |
| 2021 | $2,129 | 105 | Daiichi Sankyo Inc. ($444.27) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Highridge Medical LLC | MOBI-C PLUG & FIT US (Device) | Food and Beverage | In-kind items and services | $137.95 | General |
| Category: Spine | ||||||
| 01/31/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Oncology | ||||||
| 01/24/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Oncology | ||||||
| 12/12/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ETONOGESTREL | ||||||
| 10/18/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ETONOGESTREL | ||||||
| 09/19/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Oncology | ||||||
| 08/04/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Oncology | ||||||
| 06/02/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: Oncology | ||||||
| 05/31/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $23.76 | General |
| 05/30/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Oncology | ||||||
| 05/26/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Oncology | ||||||
| 05/15/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Oncology | ||||||
| 05/08/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Oncology | ||||||
| 05/06/2023 | PFIZER INC. | IBRANCE (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $28.41 | General |
| Category: Hematology/Oncology | ||||||
| 04/27/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 04/17/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| 04/14/2023 | Lilly USA, LLC | RETEVMO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 381 | 537 | $63,483 | $12,004 |
| 2022 | 7 | 209 | 274 | $30,254 | $7,738 |
| 2021 | 10 | 231 | 305 | $26,939 | $7,362 |
| 2020 | 1 | 11 | 13 | $104.00 | $38.46 |
Total Patients
832
Total Services
1,129
Medicare Billing
$27,142
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 98 | $26,166 | $4,834 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 65 | $26,286 | $3,645 | 13.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 71 | 115 | $1,934 | $945.28 | 48.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 51 | 97 | $2,663 | $738.17 | 27.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 14 | $2,114 | $585.48 | 27.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 50 | $1,726 | $423.85 | 24.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 30 | 38 | $1,447 | $393.30 | 27.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 20 | 24 | $816.00 | $320.64 | 39.3% |
| 83540 | Iron level | Office | 2023 | 13 | 15 | $240.00 | $95.10 | 39.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 21 | $91.00 | $24.08 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 41 | $13,120 | $3,417 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 41 | $9,307 | $2,424 | 26.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 13 | 16 | $2,544 | $691.76 | 27.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 43 | 62 | $2,418 | $475.42 | 19.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 34 | $1,190 | $319.76 | 26.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 22 | 23 | $1,219 | $240.54 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 57 | $456.00 | $168.66 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 23 | $6,871 | $1,940 | 28.2% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 20 | $6,940 | $1,923 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 25 | $5,251 | $1,490 | 28.4% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 12 | 24 | $1,800 | $504.24 | 28.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 44 | 59 | $2,301 | $458.43 | 19.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 25 | 31 | $1,643 | $327.36 | 19.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 22 | 32 | $1,056 | $304.00 | 28.8% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 14 | 16 | $544.00 | $218.08 | 40.1% |
About Olesea Bonanno, ARNP
Olesea Bonanno, ARNP is a Family healthcare provider based in Lake Oswego, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2018. The National Provider Identifier (NPI) number assigned to this provider is 1386128056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Olesea Bonanno, ARNP has received a total of $5,709 in payments from pharmaceutical and medical device companies, with $176.96 received in 2024. These payments were reported across 272 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,141).
As a Medicare-enrolled provider, Bonanno has provided services to 832 Medicare beneficiaries, totaling 1,129 services with total Medicare billing of $27,142. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Lake Oswego, OR
- Active Since 09/19/2018
- Last Updated 10/27/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1386128056
Products in Payments
- INJECTAFER (Drug) $331.15
- ERLEADA (Drug) $313.65
- VERZENIO (Drug) $299.68
- LYNPARZA (Drug) $218.54
- KISQALI (Drug) $198.30
- Enhertu (Drug) $182.41
- IMBRUVICA (Drug) $172.18
- Lenvima (Drug) $157.51
- BRUKINSA (Drug) $142.77
- PROMACTA (Drug) $142.72
- OPDIVO (Biological) $142.09
- MOBI-C PLUG & FIT US (Device) $137.95
- ADAKVEO (Biological) $116.57
- ADCETRIS (Biological) $111.78
- CYRAMZA (Drug) $109.82
- CALQUENCE (Drug) $106.72
- ZEPZELCA (Drug) $106.40
- RYBREVANT (Drug) $99.95
- KRAZATI (Drug) $89.64
- MONJUVI (Drug) $84.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lake Oswego
Courtney Vesely, Np-C, NP-C
Family — Payments: $4,987
Family $4,987
Tierney Newman, Fnp-C, FNP-C
Family — Payments: $617.50
Family $617.50
Erin Donovan, Fnp-Bc, FNP-BC
Family — Payments: $435.98
Family $435.98
Mrs. Susan Colemer, A-Gnp-C, A-GNP-C
Family — Payments: $384.18
Family $384.18
Natalya Tebor, Fnp-Bc, FNP-BC
Family — Payments: $305.16
Family $305.16
Courtney Summerskill, A.r.n.p, A.R.N.P
Family — Payments: $243.45
Family $243.45